Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas D James

Showing results (31-40 of 198) with videos related to

Pageof 20
Sort By:
Lancet (London, England)|August 2, 2016
STAMPEDE trial and patients with non-metastatic prostate cancer - Authors' replyNicholas D James, Matthew R Sydes, Noel W Clarke, et al.
BJU International|February 12, 2005
Molecular pathways in bladder cancer: part 2Richard T Bryan, Syed A Hussain, Nicholas D James, et al.
European Urology|November 21, 2018
The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate CancerJoe M O'Sullivan, Daniel Heinrich, Nicholas D James, et al.
BJUI Compass|October 21, 2022
Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancerNicholas D James, Ayesha Ali, Ann Pope, et al.
Expert Review of Anticancer Therapy|April 18, 2019
Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism?Mehran Afshar, Hiten R H Patel, Ankit Jain, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 16, 2011
Conduction failure following spinal cord injury: functional and anatomical changes from acute to chronic stagesNicholas D James, Katalin Bartus, John Grist, et al.
Glia|January 15, 2019
ErbB receptor signaling directly controls oligodendrocyte progenitor cell transformation and spontaneous remyelination after spinal cord injuryKatalin Bartus, Emily R Burnside, Jorge Galino, et al.
Frontiers in Neurology|August 10, 2017
Structural and Functional Substitution of Deleted Primary Sensory Neurons by New Growth from Intrinsic Spinal Cord Nerve Cells: An Alternative Concept in Reconstruction of Spinal Cord CircuitsNicholas D James, Maria Angéria, Elizabeth J Bradbury, et al.
Stem Cell Research & Therapy|January 7, 2021
Combined treatment with enteric neural stem cells and chondroitinase ABC reduces spinal cord lesion pathologyBenjamin Jevans, Nicholas D James, Emily Burnside, et al.
BJU International|March 23, 2026
Clinical outcomes of BCG-treated patients with high-risk non-muscle-invasive bladder cancer according to pre- and post-2021 European Association of Urology risk classificationsTian Ye, Benjamin Tura, Ben Abbotts, et al.
Pageof 20

Showing results (31-40 of 198) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|August 2, 2016
STAMPEDE trial and patients with non-metastatic prostate cancer - Authors' replyNicholas D James, Matthew R Sydes, Noel W Clarke, et al.
BJU International|February 12, 2005
Molecular pathways in bladder cancer: part 2Richard T Bryan, Syed A Hussain, Nicholas D James, et al.
European Urology|November 21, 2018
The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate CancerJoe M O'Sullivan, Daniel Heinrich, Nicholas D James, et al.
BJUI Compass|October 21, 2022
Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancerNicholas D James, Ayesha Ali, Ann Pope, et al.
Expert Review of Anticancer Therapy|April 18, 2019
Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism?Mehran Afshar, Hiten R H Patel, Ankit Jain, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 16, 2011
Conduction failure following spinal cord injury: functional and anatomical changes from acute to chronic stagesNicholas D James, Katalin Bartus, John Grist, et al.
Glia|January 15, 2019
ErbB receptor signaling directly controls oligodendrocyte progenitor cell transformation and spontaneous remyelination after spinal cord injuryKatalin Bartus, Emily R Burnside, Jorge Galino, et al.
Frontiers in Neurology|August 10, 2017
Structural and Functional Substitution of Deleted Primary Sensory Neurons by New Growth from Intrinsic Spinal Cord Nerve Cells: An Alternative Concept in Reconstruction of Spinal Cord CircuitsNicholas D James, Maria Angéria, Elizabeth J Bradbury, et al.
Stem Cell Research & Therapy|January 7, 2021
Combined treatment with enteric neural stem cells and chondroitinase ABC reduces spinal cord lesion pathologyBenjamin Jevans, Nicholas D James, Emily Burnside, et al.
BJU International|March 23, 2026
Clinical outcomes of BCG-treated patients with high-risk non-muscle-invasive bladder cancer according to pre- and post-2021 European Association of Urology risk classificationsTian Ye, Benjamin Tura, Ben Abbotts, et al.
Pageof 20